Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for RASAGILINE
- Efficacy and Safety of Rasagiline in Prodromal Parkinson's Disease
- Study to Evaluate the Pressor Effect of Oral Tyramine During Ozanimod Treatment in Healthy Adult Participants
- Trial of Oxaloacetate in ALS
- Overnight Switch From Rasagiline To Safinamide
- A Phase 3 Study With P2B001 in Subjects With Early Parkinson's
- Image Parkinson's Disease Progression Study
- Azilect® In Wearing-Off (AIWO)
- Rasagiline Rescue in Alzheimer's Disease Clinical Trial
- Effect of 2.5 Years of Rasagiline Therapy on Progression of Cognitive Biomarkers Assessed by MRI in Parkinson's Disease.
- Ambulosono Rasagiline Musical Walking Study
- Rasagiline (Azilect) - Neuroprotection for Macula-off Retinal Detachment
- Safety, Tolerability and Efficacy of Two Doses of Once Daily P2B001 in Subjects With Early Parkinson's Disease
- A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Rasagiline
- Study of Rasagiline in Patients With Amyotrophic Lateral Sclerosis
- Rasagiline in Subjects With Amyotrophic Lateral Sclerosis (ALS)
- Evaluation of the Efficacy of Rasagiline in Apathy in Drug-naïve Patients With Parkinson's Disease by a Multi-center Study
- Clinical Trial of Rasagiline in Levodopa-Treated Parkinson's Disease Patients With Motor Fluctuations
- Parallel-Group Study to Assess the Effect of Rasagiline on Cognition in Patients With Parkinson's Disease
- Pharmacokinetic Properties of Rasagiline (Lu 00-773) in Healthy Young Chinese Men and Women
- Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa in China
- Effect of Rasagiline on BIA 9-1067 Pharmacokinetics
- Effect of BIA 9-1067 on Rasagiline Pharmacokinetics
- A Double Blind Placebo Controlled Trial Evaluating Rasagiline Effects on Cognition in Parkinson's Disease Patients With Mild Cognitive Impairment Receiving Dopaminergic Therapy
- Azilect® (Rasagiline) in Levodopa-treated Parkinson's Patients With Motor Fluctuations in China
- Effects of Rasagiline on Sleep Disturbances in Parkinson's Disease
- Emotion, Mood and Executive Function in Parkinson's Disease (PD)
- The Effect of Rasagiline on Cognition in Parkinson's Disease
- Pioglitazone in Early Parkinson's Disease
- Study of Azilect® (Rasagiline) in Levodopa-treated Parkinson's Disease Patients With Motor Fluctuations in Korea
- Trial of Safety and Efficacy of Rasagiline in Patients With Amyotrophic Lateral Sclerosis (ALS)
- An Active-Controlled Extension Study to NCT01155466 [P04938] and NCT01227265 [P07037] (P06153)
- Safety and Efficacy of Rasagiline in Restless Legs Syndrome
- Efficacy, Tolerability and Safety of Azilect in Subjects With Progressive Supranuclear Palsy
- Multicenter Placebo Controlled Study to Assess the Effect of Rasagiline on Sleep-wake Disturbances in Patients With Parkinson's Disease
- Rasagiline for the Symptomatic Treatment of Fatigue in Parkinson's Disease
- Rasagiline in Cognitive-impairment Related Depression: AzileCt in COgnitive-impairment Related DepressiOn
- Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease
- Evaluation of the Tolerance and Acceptability of Rasagiline in the Treatment of Early-stage Parkinson's Disease
- Study for Rasagiline Effect on Sleep Trial(REST)in Parkinson's Disease
- A Study Assessing Change in Sense of Smell After Rasagiline Use in Parkinson's Patients
- Clinical Trial to Assess Efficacy, Safety, and Tolerability of Rasagiline Mesylate 1 mg in Patients With Multiple System Atrophy of the Parkinsonian Subtype (MSA-P)
- Azilect + Antidepressant Chart Review
- ADAGIO Follow Up Study: Evaluation of the Long-Term Effects of Rasagiline in Parkinson's Disease Subjects
- Olfaction in Patients With Parkinson's Disease Following Treatment With Rasagiline
- Rasagiline and Apathy in Parkinson's Disease
- The Effects of Rasagiline on Cognitive Deficits Associated With Parkinson's Disease
- Tolerability and Efficacy of Switch From Oral Selegiline to Orally Disintegrating Selegiline (Zelapar) in Patients With Parkinson's Disease
- Rasagiline in the Treatment of Persistent Negative Symptoms of Schizophrenia
- A Randomized Placebo Controlled Study to Show That Rasagiline May Slow Disease Progression for Parkinson's Disease
- Rasagiline in Advanced Parkinson's Disease Patients With Motor Fluctuations Treated With Levodopa/Carbidopa Therapy.
- Study to Evaluate the Safety and Tolerability of Rasagiline in Advanced Parkinson's Disease Patients
- Safety, Tolerability, and Effectiveness of Rasagiline Mesylate in Patients With Parkinson's Disease
- A Study to Evaluate the Effects of Tyramine in Patients Who Completed the PRESTO Study.
- Effectiveness, Tolerability and Safety of Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa
- Multicenter Study of Rasagiline in Parkinson's Disease Patients Using Levodopa and Experiencing Motor Fluctuations
- Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD)
Clinical trials list
click for details